Jerash Holdings (US) Inc. Common Stock (JRSH)

FairStock Score: 62/100 — STEADY

Key Financials

Strengths

• Conservative balance sheet with debt-to-equity of just 0.15, providing financial flexibility
• Revenue growth of 18.0% demonstrates strong top-line momentum
• Attractive 6.0% dividend yield providing steady income returns

AI Analysis

Jerash Holdings (US) Inc. Common Stock is a micro-cap consumer cyclical company valued at $43 million. The business generates $153 million in annual revenue with a 0.8% net margin. From a quality standpoint, Jerash shows Altman Z-Score of 3.0 in the grey zone and modest 3% ROE. On valuation, the stock is reasonably priced at 24.1x earnings, with a modest 15% margin of safety vs Graham Number. Growth dynamics show revenue growing at 18.0% and profit growth of 20261.5%. The 6.0% dividend yield adds an income component for patient holders. Our composite FairStock Score of 62/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Jerash's 18% revenue growth trajectory could accelerate as it captures additional market share in the consumer cyclical sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the consumer cyclical space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer